A search for acrolein scavengers among food components

doi:10.21203/rs.3.rs-2232431/v1

Download PDF

Research Article

A search for acrolein scavengers among food components

https://doi.org/10.21203/rs.3.rs-2232431/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 08 Feb, 2023

Read the published version in Amino Acids →

You are reading this latest preprint version

Brain stroke is a major cause of being bedridden for elderly people, and preventing stroke is important for maintaining quality of life (QOL). Acrolein is a highly reactive aldehyde and causes tissue damage during stroke. Decreasing acrolein toxicity ameliorates tissue injury during brain stroke. In this study, we tried to identify food components which decrease acrolein toxicity. We found that 2-furanmethanethiol, cysteine methyl and ethyl esters, alliin, lysine and taurine decreased acrolein toxicity. These compounds neutralized acrolein by direct interaction. However, the interaction between acrolein and taurine was not so strong. Approximately 30 mM taurine was necessary to interact with 10 µM acrolein, and 2 g/kg taurine was necessary to decrease the size of mouse brain infarction. Taurine also slightly increased polyamine contents, which are involved in decrease in the acrolein toxicity. Mitochondrial potential damage by acrolein was also protected by taurine. Our results indicate that daily intake of foods containing 2-furanmethanethiol, cysteine methyl and ethylesters, alliin, lysine and taurine may prevent severe injury in brain stroke and improve the quality of life for elderly people.

Acrolein scavengers

brain stroke

taurine

polyamine

mitochondria

Brain stroke is a severe symptom caused by a blockage of brain blood vessels and the main cause of being bedridden for elderly people. Stroke is also a leading cause of dementia and depression (Johnson et al. 2016). Approximately 15 million people suffer a brain stroke each year worldwide (http://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html). As stroke incidence and severity increase during aging (Nakayama et al. 1994; Uemura et al. 2016), this disease is one of the primary reasons for disability among the elderly. Since the number of people of advanced age is increasing globally, finding a novel method to prevent and treat brain stroke is important.

We have reported that acrolein (CH₂ = CH-CHO), an unsaturated aldehyde, is strongly involved in tissue damage in brain stroke (Igarashi et al. 2018). Compared to reactive oxygen species (ROS), such as hydrogen peroxide, that exerts cell growth inhibition at 0.2–0.4 mM, acrolein is much more toxic as it inhibits cell growth at several µM level (Sharmin et al. 2001; Yoshida et al. 2009). Acrolein is produced mainly by oxidation of the polyamine spermine in vivo (Pegg 2013), easily reacts with proteins, and acrolein-conjugated proteins contribute to cytotoxicity. Acrolein inactivates GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Nakamura et al. 2013), and disrupts the cytoskeleton by conjugating with tubulin (Uemura et al. 2019), vimentin and actin (Uemura et al. 2020). Acrolein is also involved in the tissue damage of Sjögren's syndrome patients by activating matrix metalloproteinase-9 (Uemura et al. 2017). Related to metabolic syndrome, acrolein-modified low-density lipoprotein can be taken up by macrophages via scavenger receptor class A type 1 (SR-A1), resulting in foam cell formation (Kobayashi et al. 2021; Watanabe et al. 2013). Administration of acrolein scavenger N-acetylcysteine and its derivatives decreased the size of brain infarction in a mouse model by increasing the stability of glutathione S-transferases that are involved in acrolein detoxification (Uemura et al. 2018). This suggests that effective acrolein scavengers can be a preventive agent for brain stroke. Accordingly, we looked for food components which can detoxify acrolein toxicity.

Cell culture

Mouse neuroblastoma-derived Neuro2a cells were cultured in Dulbecco’s Minimal Essential Medium (MEM) supplemented with 50 U/ml streptomycin, 100 U/ml penicillin G and 10% fetal bovine serum at 37°C in an atmosphere of 5% CO₂. For cell growth analysis, cells were inoculated at 2 × 10⁵ cells/well to 6-well plates (BD Falcon, the size of growing area is approximately 10 cm²/well) and cultured for 12 h. Then, 10 µM acrolein (Tokyo Chemical Industry, Tokyo, Japan), and 2-furanmethanthiol (Tokyo Chemical Industry), cysteine methyl ester and ethyl ester (Tokyo Chemical Industry), alliin (Sigma-Aldrich), lysine (Nacalai Tesque) and taurine (Nacalai Tesque) at the indicated concentrations, were added to the medium, and cell growth was followed for 3 days. The viability of cells was monitored by staining with 0.2% trypan blue solution.

Measurements of glutathione, taurine, polyamine and protein contents

Glutathione and taurine contents in cells were determined using a Glutathione Assay Kit (Cayman Chemical) and a Taurine Assay Kit (Cell Biolabs), respectively. Cells were washed three times with ice-cold phosphate buffered saline (PBS), homogenized in MES buffer containing 0.4 M 2-(N-morpholino)ethanesulphonic acid, 0.1 M phosphate and 2 mM EDTA, pH 6.0, and mixed with an equal volume of 0.2 M trichloroacetic acid at 4°C for 10 min. After centrifugation, supernatants were diluted with MES buffer and total glutathione and taurine contents were measured according to the manufacturer’s protocol. Polyamine contents in cells were determined as described previously (Igarashi et al. 1986). Protein contents in cells were determined with a BCA protein assay kit (Nacalai Tesque) using bovine serum albumin as a standard.

Photochemically-induced thrombosis (PIT) model mice

All animal experiments were approved by the Institutional Animal Care and Use Committee of Chiba University and carried out according to the Guidelines for Animal Research of Chiba University. PIT model mice were prepared using 8-week-old male C57BL/6 mice (22–26 g) as described previously (Saiki et al. 2009). Taurine was administered intraperitoneally, just before the induction of infarction. The efficacy of taurine was calculated as the volume of decreased infarction per 2 g administered per kg of mouse body weight. No mouse presented signs of paresis, convulsion, remarkable weight loss or any other symptoms.

Measurement of the level of free acrolein in the presence of anti-acrolein reagents

Free acrolein was measured according to the method of Alarcon (Alarcon 1968). The reaction mixture (0.3 mL) containing 67 mM Na⁺-phosphate buffer, pH 7.5, 10 µM acrolein, and reagents at indicated concentrations was incubated at 37 ºC for 2.5, 5, 10 and 20 min. At each interval, 50 µL of the reaction mixture was taken out and mixed with an equal volume of solution containing 92 mM m-aminophenol, 172 mM hydroxylamine hydrochloride and 3 M HCl. After the mixture was boiled for 10 min, acrolein content was determined by HPLC according to the method of Bohnenstengel et al. (Bohnenstengel et al. 1997), using 10 µL supernatant after centrifugation. Fluorescence of 7-hydroxyquinoline (an acrolein derivative) was measured at an excitation wavelength of 358 nm and an emission wavelength of 510 nm.

Western blotting

Cells were washed with PBS and lysed in RIPA buffer (Nacalai Tesque) containing 10 µg/ml aprotinin, 500 µM sodium orthovanidate and 10 µg/ml phenylmethylsulfonyl fluoride. Proteins were separated on a 10% SDS-polyacrylamide gel and transferred electrophoretically to Immobilon-E transfer membranes (Merck Millipore). Blots were blocked in 5% nonfat dry milk in tris-buffered saline containing 0.1% Tween 20 (TBS-T) for 30 min at room temperature. The levels of specific proteins were detected with an ECL Western Blotting Detection System (GE Healthcare) using anti-ODC1 (Proteintech), anti-AMD1 (Cell Signaling Technology), anti-spermidine synthase (Proteintech), anti-spermine synthase (Proteintech), anti-SMO (Abcam), anti-AcPAO (Abcam), anti-SSAT1 (Abcam), anti-protein conjugated acrolein (PC-Acro, Takara Bio, Japan) and anti-actin (Santa Cruz Biotechnology). Images were captured using an Amersham Imager 600 (GE Healthcare) and bands were quantified using the ImageJ program (Schneider et al. 2012), normalized to actin and expressed as relative amount.

Staining of mitochondria

Neuro2a cells were cultured with or without 10 µM acrolein and/or 30 mM taurine for 3 days. Cells were then washed with fresh medium and incubated with 0.5 µM MitoTracker Orange (Invitrogen) and 1 µg/ml Hoechst 33342 (Sigma-Aldrich) for 30 min at 37ºC in a fresh medium. Fluorescence was observed under an Evos FL Auto2 fluorescence microscope with Celleste image analysis software (Invitrogen). All images were captured in the same settings of microscope and any cropping or adjustment was applied.

Statistical analysis

Statistical analysis was performed as described previously (Uemura et al. 2019). For comparison of multiple groups, one-way ANOVA followed by Bonferroni’s multiple comparisons test was used.

Food components which decreased acrolein toxicity

Acrolein is a strongly toxic compound for cells and attacks cysteine, lysine and histidine residues in proteins to form protein-conjugated acrolein (PC-Acro) (Igarashi et al. 2018). Since a thiol group reacts preferentially with acrolein (Danyal et al. 2016), we sought food components containing a sulfur atom as acrolein scavengers. Mouse neuroblastoma derived Neuro2a cells were incubated with acrolein and several compounds to assess cytotoxicity. As shown in Fig. 1, 10 µM acrolein inhibited cell growth. Addition of 10 µM 2-furanmethanthiol (2-FMT), a flavor component of coffee, 30 µM cysteine methyl and ethyl esters (CysMe and CysEt), contained in green onions, together with acrolein recovered cell growth. Alliin (100 µM), a garlic component, lysine (10 mM), high in red meat and beans, and taurine (30 mM), which is rich in squids and clams, also diminished the inhibitory effect of acrolein on cell growth.

Acrolein conjugation activity of food derived compounds

The ability of compounds to neutralize acrolein was then analyzed by acrolein conjugation assay. Acrolein and compounds were incubated together and the remaining free acrolein was measured by HPLC. As shown in Fig. 2, 10 µM 2-FMT, 30 µM CysMe and CysEt, and 100 µM allin rapidly neutralized free acrolein. Lysine (10 mM) and taurine (30 mM) also are able to conjugate acrolein, although a high concentration was necessary. This suggests that taurine may reduce acrolein toxicity via a different mechanism together with the direct elimination of acrolein.

Recovery of glutathione contents by acrolein scavengers

Glutathione is a natural detoxifier for acrolein in tissue (Tomitori et al. 2012). Thus, the effect of compounds on the level of glutathione was examined. As shown in Fig. 3, although acrolein treatment significantly decreased glutathione content, addition of acrolein scavengers recovered glutathione to normal levels. These results suggest that the compounds interact with acrolein and disturb acrolein conjugation with glutathione, which was observed in N-acetylcysteine administrated into mouse brain after induction of infarction (Uemura et al. 2018).

Effect of taurine on brain infarction and cell growth of acrolein-treated Neuro2a cells

It was then determined whether taurine changes the size of brain infarction in mice, because acrolein scavengers N-acetylcysteine and its derivatives decreased the size of brain infarction (Uemura et al. 2018). As shown in Fig. 4A, addition of 2 g/kg taurine significantly decreased the size of brain infarction.

How the taurine content changes in the presence of acrolein in Neuro2a cells was investigated. As shown in Fig. 4B, the addition of 10 µM acrolein slightly increased the content of taurine. If the intracellular water space of Neuro2a cells was similar to rat liver cells (5.5 µl cell volume/mg protein (Watanabe et al. 1991)), taurine concentration increased approximately from 10 mM to 15 mM by addition of 10 µM acrolein. However, inhibition of cell growth was not recovered. When 30 mM taurine was added, intracellular taurine concentration increased to approximately 30 mM, at which concentration acrolein was detoxified (see Fig. 1). The results indicate that more than 30 mM taurine are necessary to detoxify acrolein toxicity.

Effect of acrolein and its scavengers on polyamine contents

We next studied how acrolein scavengers influence polyamine content in cells. Polyamine content did not change significantly by the addition of acrolein scavengers except taurine (Fig. 5). Taurine significantly increased both putrescine and spermidine contents, but spermine content was not affected.

Polyamines possess two primary amino groups that potentially react with acrolein (Tsutsui et al. 2014). To test whether polyamines can neutralize free acrolein, an acrolein conjugation assay was performed. As shown in Fig. 6A, putrescine, spermidine and spermine interacted with acrolein. These results suggest that the increase in polyamine content caused by taurine may contribute to acrolein detoxification through interaction with free acrolein.

The levels of polyamine biosynthetic and degrading enzymes were then measured to confirm the effect of taurine on polyamine contents. As shown in Fig. 6B, ornithine decarboxylase (ODC), a rate limiting enzyme for polyamine biosynthesis (Pegg 2006), was slightly decreased in acrolein-treated cells and increased in taurine-treated cells. Taurine treatment counteracted the decrease in ODC level by acrolein. S-adenosylmethionine decarboxylase 1 (AMD1), another rate-limiting enzyme for polyamine biosynthesis (Lim et al. 2018), was significantly decreased by acrolein, and taurine slightly recovered the decrease. Spermidine synthase (SPDS) was not affected by either acrolein or taurine treatment. Spermine synthase (SPMS) decreased greatly by acrolein treatment, but taurine slightly recovered the level of SPMS. Spermine oxidase (SMO), which catalyzes spermine degradation to produce acrolein, was increased slightly by acrolein. Another polyamine degradation pathway consisting of acetylpolyamine oxidase (AcPAO) and spermidine/spermine N¹-acetyltransferase (SSAT) (Battaglia et al. 2014) was not affected by acrolein and taurine treatment. These results suggest that the increase in putrescine and spermidine levels in taurine-treated cells may be partially involved in the detoxification of acrolein by taurine.

Protective effect of taurine on mitochondrial damage by acrolein

There are reports that acrolein targets mitochondrial potential and induces cellular oxidative stress (Mohammad et al. 2012; Sun et al. 2006; Wu et al. 2020). It is also reported that taurine is identified as a constituent of mitochondrial tRNAs (Suzuki et al. 2002), and is known to be important for mitochondrial function (Jong et al. 2021). As shown in Fig. 7, 20 µM acrolein diminished mitochondrial potential. When cells were treated with 30 mM taurine, the mitochondrial potential was retained after acrolein exposure. These results indicate that taurine protects mitochondria from acrolein damage.

In this study, we sought food components which reduce acrolein toxicity to identify novel anti-stroke compounds. Our previous work demonstrated that cysteine derivatives ameliorated tissue injury of brain stroke in a mouse model (Uemura et al. 2018). Thus, we tested the acrolein detoxification effect of sulfur containing compounds. Thiol compounds, i.e. 2-FMT and cysteine methyl and ethyl esters counteracted acrolein toxicity at 10–30 µM (Fig. 1). These compounds neutralized free acrolein in less than 20 seconds (Fig. 2), and prevented the decrease of glutathione by acrolein (Fig. 3). The results indicate that 2-FMT and cysteine methyl and ethyl esters neutralize free acrolein and rescued cells from acrolein toxicity. We suggest that taking foods and drink containing these components such as green onion and coffee can offer a benefit for preventing brain stroke.

We also found that sulfur-containing compounds alliin and taurine, and the amino acid lysine decreased acrolein toxicity. Alliin and lysine neutralized free acrolein even slower compared to 2-FMT and cysteine methyl and ethyl esters, but this ability to neutralize acrolein probably contributes to the acrolein detoxification. Interestingly, high concentrations of taurine rescued cells from acrolein toxicity. Taurine not only neutralizes acrolein weakly (Fig. 2), but also increases putrescine and spermidine levels (Fig. 5). These polyamines also neutralized acrolein (Fig. 6), suggesting that the increase in polyamine content is also involved in the decrease in acrolein toxicity by taurine. Western blot analysis revealed that ODC1 and AMD1, both of which are rate-limiting enzymes in polyamine synthesis (Pegg 2016), are upregulated by taurine in the presence of acrolein (Fig. 6). Acrolein also diminished mitochondrial potential (Fig. 7), but taurine protected the decrease in the mitochondrial potential from acrolein. These results indicate that taurine decreases acrolein toxicity due to direct interaction with acrolein as well as through the increases in polyamine contents and mitochondrial functions. Taurine (2 g/kg) could decrease significantly the size of brain infarction (Fig. 4). Recently, it has been reported that taurine chloramine (0.5 mg/kg) protects against postischemic brain injury (Seol et al. 2021). However, this may be due to the presence of chloramine together with taurine.

Brain stroke is one of the major causes of the decrease in quality of life (QOL) in the elderly (Johnson et al. 2016). Our results suggest that daily intake of foods and drink containing thiol compounds (2-FMT, CysMe and CysEt), alliin, lysine and taurine, such as coffee, garlic, green onions, beans, squid and clams is probably useful to prevent severe injury in brain stroke and to improve QOL.

AcPAO Acetylpolyamine oxidase

AMD S-Adenosylmethionine decarboxylase

2-FMT 2-Furanmethanthiol

GAPDH Glyceraldehyde-3-phosphate dehydrogenase

ODC Ornithine decarboxylase

PC-Acro Protein-conjugated acrolein

QOL Quality of life

ROS Reactive oxygen species

SMO Spermine oxidase

SSAT Spermidine/spermine N¹-acetyltransferase.

Acknowledgements We thank Dr. A. J. Michael for his help in preparing this manuscript.

Competing interests The authors declare there is no competing interests.

Authors’ contributions Investigation, TU, MU, MN, MS, AS, YT, KH, II; Writing-Original draft preparation, TU; Conceptualization, KK, KI; Writing-Reviewing and Editing, KI; Funding acquisition, KK.

Funding This work was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Cultures, Sports, Science and Technology, Japan (21K06714).

Ethical approval All procedures performed in studies involving human participants and animals were in accordance with the ethical standards of the ethics committee of Chiba University and with the 1964 Helsinki declaration and the later amendments or comparable ethics standards.

Alarcon RA (1968) Fluorometric determination of acrolein and related compounds with m-aminophenol. Anal Chem 40:1704–1708
Battaglia V, DeStefano Shields C, Murray-Stewart T, Casero RA, Jr. (2014) Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention. Amino Acids 46:511–519
Bohnenstengel F, Eichelbaum M, Golbs E, Kroemer HK (1997) High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes. J Chromatogr B Biomed Sci Appl 692:163–168
Danyal K, de Jong W, O'Brien E, Bauer RA, Heppner DE, Little AC, Hristova M, Habibovic A, van der Vliet A (2016) Acrolein and thiol-reactive electrophiles suppress allergen-induced innate airway epithelial responses by inhibition of DUOX1 and EGFR. Am J Physiol Lung Cell Mol Physiol 311:L913-L923
Igarashi K, Kashiwagi K, Hamasaki H, Miura A, Kakegawa T, Hirose S, Matsuzaki S (1986) Formation of a compensatory polyamine by Escherichia coli polyamine-requiring mutants during growth in the absence of polyamines. J Bacteriol 166:128–134
Igarashi K, Uemura T, Kashiwagi K (2018) Acrolein toxicity at advanced age: present and future. Amino Acids 50:217–228
Johnson W, Onuma M, Owolabi M, Sachdev S (2016). B World Health Organ 94:634-634A
Jong CJ, Sandal P, Schaffer SW (2021) The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant. Molecules 26:4913
Kobayashi M, Watanabe K, Suzuki T, Dohmae N, Fujiyoshi M, Uchida M, Suzuki T, Igarashi K, Ishii I (2021) Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL. Biochim Biophys Acta Mol Cell Biol Lipids 1866:158809
Lim HK, Rahim AB, Leo VI, Das S, Lim TC, Uemura T, Igarashi K, Common J, Vardy LA (2018) Polyamine regulator AMD1 promotes cell migration in epidermal wound healing. J Invest Dermatol 138:2653–2665
Mohammad MK, Avila D, Zhang J, Barve S, Arteel G, McClain C, Joshi-Barve S (2012) Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicol Appl Pharmacol 265:73–82
Nakamura M, Tomitori H, Suzuki T, Sakamoto A, Terui Y, Saiki R, Dohmae N, Igarashi K, Kashiwagi K (2013) Inactivation of GAPDH as one mechanism of acrolein toxicity. Biochem Biophys Res Commun 430:1265–1271
Nakayama H, Jorgensen HS, Raaschou HO, Olsen TS (1994) The influence of age on stroke outcome. The Copenhagen Stroke Study. Stroke 25:808–813
Pegg AE (2006) Regulation of ornithine decarboxylase. J Biol Chem 281:14529–14532
Pegg AE (2013) Toxicity of polyamines and their metabolic products. Chem Res Toxicol 26:1782–1800
Pegg AE (2016) Functions of Polyamines in Mammals. J Biol Chem 291:14904–14912
Saiki R, Nishimura K, Ishii I, Omura T, Okuyama S, Kashiwagi K, Igarashi K (2009) Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 40:3356–3361
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
Seol SI, Kim HJ, Choi EB, Kang IS, Lee HK, Lee JK, Kim C (2021) Taurine protects against postischemic brain injury via the antioxidant activity of taurine chloramine. Antioxidants (Basel) 10
Sharmin S, Sakata K, Kashiwagi K, Ueda S, Iwasaki S, Shirahata A, Igarashi K (2001) Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 282:228–235
Sun L, Luo C, Long J, Wei D, Liu J (2006) Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 6:136–142
Suzuki T, Suzuki T, Wada T, Saigo K, Watanabe K (2002) Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J 21:6581–6589
Tomitori H, Nakamura M, Sakamoto A, Terui Y, Yoshida M, Igarashi K, Kashiwagi K (2012) Augmented glutathione synthesis decreases acrolein toxicity. Biochem Biophys Res Commun 418:110–115
Tsutsui A, Imamaki R, Kitazume S, Hanashima S, Yamaguchi Y, Kaneda M, Oishi S, Fujii N, Kurbangalieva A, Taniguchi N, Tanaka K (2014) Polyamine modification by acrolein exclusively produces 1,5-diazacyclooctanes: a previously unrecognized mechanism for acrolein-mediated oxidative stress. Org Biomol Chem 12:5151–5157
Uemura T, Suzuki T, Ko K, Nakamura M, Dohmae N, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K (2020) Structural change and degradation of cytoskeleton due to the acrolein conjugation with vimentin and actin during brain infarction. Cytoskeleton (Hoboken) 77:414–421
Uemura T, Suzuki T, Ko K, Watanabe K, Dohmae N, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K (2019) Inhibition of dendritic spine extension through acrolein conjugation with a-, b-tubulin proteins. Int J Biochem Cell Biol 113:58–66
Uemura T, Suzuki T, Saiki R, Dohmae N, Ito S, Takahashi H, Toida T, Kashiwagi K, Igarashi K (2017) Activation of MMP-9 activity by acrolein in saliva from patients with primary Sjogren's syndrome and its mechanism. Int J Biochem Cell Biol 88:84–91
Uemura T, Watanabe K, Ishibashi M, Saiki R, Kuni K, Nishimura K, Toida T, Kashiwagi K, Igarashi K (2016) Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging. Biochem Biophys Res Commun 473:630–635
Uemura T, Watanabe K, Ko K, Higashi K, Kogure N, Kitajima M, Takayama H, Takao K, Sugita Y, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K (2018) Protective effects of brain infarction by N-acetylcysteine derivatives. Stroke 49:1727–1733
Watanabe K, Nakazato Y, Saiki R, Igarashi K, Kitada M, Ishii I (2013) Acrolein-conjugated low-density lipoprotein induces macrophage foam cell formation. Atherosclerosis 227:51–57
Watanabe S, Kusama-Eguchi K, Kobayashi H, Igarashi K (1991) Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem 266:20803–20809
Wu X, Cui W, Guo W, Liu H, Luo J, Zhao L, Guo H, Zheng L, Bai H, Feng D, Qu Y (2020) Acrolein aggravates secondary brain injury after intracerebral hemorrhage through Drp1-mediated mitochondrial oxidative damage in mice. Neurosci Bull 36:1158–1170
Yoshida M, Tomitori H, Machi Y, Hagihara M, Higashi K, Goda H, Ohya T, Niitsu M, Kashiwagi K, Igarashi K (2009) Acrolein toxicity: Comparison with reactive oxygen species. Biochem Biophys Res Commun 378:313–318

No competing interests reported.

Download PDF

Journal Publication

published 08 Feb, 2023

Read the published version in Amino Acids →

Editorial decision: Accepted
31 Jan, 2023
Reviews received at journal
14 Dec, 2022
Reviewers agreed at journal
30 Nov, 2022
Reviews received at journal
08 Nov, 2022
Reviewers agreed at journal
07 Nov, 2022
Reviewers invited by journal
07 Nov, 2022
Editor assigned by journal
05 Nov, 2022
Submission checks completed at journal
05 Nov, 2022
First submitted to journal
03 Nov, 2022

You are reading this latest preprint version

A search for acrolein scavengers among food components

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials And Methods

Cell culture

Measurements of glutathione, taurine, polyamine and protein contents

Photochemically-induced thrombosis (PIT) model mice

Measurement of the level of free acrolein in the presence of anti-acrolein reagents

Western blotting

Staining of mitochondria

Statistical analysis

Results

Food components which decreased acrolein toxicity

Acrolein conjugation activity of food derived compounds

Recovery of glutathione contents by acrolein scavengers

Effect of taurine on brain infarction and cell growth of acrolein-treated Neuro2a cells

Effect of acrolein and its scavengers on polyamine contents

Protective effect of taurine on mitochondrial damage by acrolein

Discussion

Abbreviations

Declarations

References

Additional Declarations

Status:

Journal Publication

Version 1